Green Pharmacy | Natural Products Sourcebook

Trevi Therapeutics Announces Publication of Data from the Phase 2b IPF Chronic Cough Trial of nalbuphine ER in the Journal of the American Medical Association (JAMA) - Morningstar

Submitted by Anonymous (not verified) on Thu, 01/22/2026 - 17:30

Trevi Therapeutics Announces Publication of Data from the Phase 2b IPF Chronic Cough

Read more about Trevi Therapeutics Announces Publication of Data from the Phase 2b IPF Chronic Cough Trial of nalbuphine ER in the Journal of the American Medical Association (JAMA) - Morningstar
Log in to post comments

Pages